Spire Healthcare Group (SPI) Rating Reiterated by Liberum Capital
Spire Healthcare Group (LON:SPI)‘s stock had its “hold” rating reiterated by Liberum Capital in a report released on Tuesday. They presently have a GBX 270 ($3.66) target price on the stock. Liberum Capital’s target price suggests a potential upside of 6.38% from the stock’s previous close.
Several other research firms have also commented on SPI. Berenberg Bank raised shares of Spire Healthcare Group to a “buy” rating and lifted their price target for the company from GBX 270 ($3.66) to GBX 310 ($4.20) in a research report on Wednesday, November 29th. Numis Securities reaffirmed an “add” rating and set a GBX 341 ($4.62) price target on shares of Spire Healthcare Group in a research report on Monday, October 23rd. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a GBX 339 ($4.60) price target on shares of Spire Healthcare Group in a research report on Thursday, January 4th. Finally, Jefferies Group dropped their target price on shares of Spire Healthcare Group from GBX 350 ($4.75) to GBX 259 ($3.51) and set a “hold” rating for the company in a report on Monday, September 25th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of GBX 309.17 ($4.19).
Spire Healthcare Group (LON SPI) traded up GBX 3.80 ($0.05) during mid-day trading on Tuesday, hitting GBX 253.80 ($3.44). 558,989 shares of the stock traded hands, compared to its average volume of 1,280,000. The stock has a market cap of $1,020.00 and a price-to-earnings ratio of 3,625.71. Spire Healthcare Group has a 1 year low of GBX 218.20 ($2.96) and a 1 year high of GBX 362.10 ($4.91).
In other Spire Healthcare Group news, insider Peter R. Bamford purchased 5,000 shares of the company’s stock in a transaction on Monday, November 27th. The stock was acquired at an average price of GBX 240 ($3.25) per share, for a total transaction of £12,000 ($16,273.39). Also, insider Justin Ash purchased 84,500 shares of the company’s stock in a transaction on Thursday, November 23rd. The stock was acquired at an average price of GBX 237 ($3.21) per share, with a total value of £200,265 ($271,582.59).
COPYRIGHT VIOLATION NOTICE: This story was reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://www.watchlistnews.com/spire-healthcare-group-spi-rating-reiterated-by-liberum-capital/1812275.html.
About Spire Healthcare Group
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.